Lantus
Product Images NDC 64725-2220

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Lantus (NDC 64725-2220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 2220)

Label for Lantus Insulin 100 Units/mL (10 mL) by Aventis, repackaged by T.Y.A. Pharmaceuticals, Tallahassee, FL. The label includes prescription status, lot number, expiration date placeholders, a barcode, and dosing instruction to see the package insert.*

FDA Label Image

Chemical Structure (Lantus 01)

Chemical structure diagram depicting the amino acid sequences and disulfide bonds of the A and B chains of insulin, showing the arrangement and linkage of amino acids in both chains.*

FDA Label Image

Figure (Lantus 02)

A line graph comparing glucose utilization rates over time after subcutaneous injection for two insulin types: insulin glargine and NPH insulin, each with 20 subjects. The x-axis shows time in hours from 0 to 30, and the y-axis shows glucose utilization rate in μmol/kg/min from 0 to 6. Insulin glargine has a relatively stable glucose utilization rate, while NPH insulin shows a pronounced peak early before declining. An arrow marks the end of the observation period.*

FDA Label Image

Figure (Lantus 03)

An instructional diagram showing a close-up of hands preparing a vial, likely for drug use. One hand holds the vial steady while the other hand removes the vial's cap. The image depicts a step in medication preparation, possibly for an injectable drug.*

FDA Label Image

Figure (Lantus 04)

An instructional illustration showing a person inserting a needle into a vial, preparing to draw medication with a syringe. The image focuses on hand positioning and needle insertion technique, commonly used for injectable drugs like Lantus.*

FDA Label Image

Figure (Lantus 05)

An instructional illustration showing a person drawing liquid medication from a vial into a syringe. The hands are positioned to hold the vial upside down and pull back the syringe plunger, demonstrating the preparation of an injectable drug dose.*

FDA Label Image

Figure (Lantus 06)

An instructional illustration showing the preparation of an injection. One hand is holding a vial, and the other hand is inserting a syringe needle into the vial to draw up liquid. The image depicts a step in preparing a dose for injection.*

FDA Label Image

Figure (Lantus 07)

An instructional illustration showing a hand holding a prefilled insulin syringe, demonstrating how to prepare or use the injection pen. The image focuses on the method of handling and potentially attaching or adjusting the needle of the device for Lantus insulin injection.*

FDA Label Image

Figure (Lantus 08)

An instructional illustration showing how to prepare an injection using a syringe. The image depicts a hand holding the vial and another hand drawing liquid from the vial into the syringe, with an arrow indicating the motion to pull the plunger downward.*

FDA Label Image

Figure (Lantus 09)

An instructional line drawing showing a person holding a Lantus insulin injection pen. The illustration depicts the hand gripping the pen, highlighting the correct orientation and method for self-administration of the injection.*

FDA Label Image

Figure (Lantus 10)

An instructional illustration showing a hand gripping a syringe and preparing to push the plunger. An arrow indicates the direction of movement for the plunger, suggesting the action of injecting or expelling liquid from the syringe.*

FDA Label Image

Figure (Lantus 11)

An instructional diagram showing the parts of a Lantus SoloStar insulin pen by TYA Pharmaceuticals. It labels the pen cap, pen needle components (outer needle cap, inner needle cap, protective seal, needle), and pen body features including the insulin reservoir, rubber seal, dosage selector, dose window, and injection button.*

FDA Label Image

Figure (Lantus 12)

An instructional illustration showing hands removing the cap from a prefilled insulin pen and holding the pen, presumably preparing it for use. The pen features a dose window and graduated markings along the barrel.*

FDA Label Image

Figure (Lantus 13)

An instructional diagram showing a hand holding a syringe attached to a vial stopper. A red X mark overlays the image, indicating an action that should not be done, likely advising against mixing or preparing the injection in this manner.*

FDA Label Image

Figure (Lantus 14)

Instructional illustration showing a hand removing or attaching the needle cap on a Lantus insulin pen. The red arrow indicates the direction to pull or twist the cap for proper removal or attachment before injection.*

FDA Label Image

Figure (Lantus 15)

Illustration showing the assembly and disposal instructions for a Lantus insulin pen needle. It depicts the needle to be kept and a protective cover to be discarded. The image uses arrows to indicate the proper handling steps for the needle and pen connection.*

FDA Label Image

Figure (Lantus 16)

An instructional diagram showing a close-up of a syringe with a needle cap. The illustration highlights removing the protective cap from the syringe needle, depicting the correct hand positioning for this step.*

FDA Label Image

Figure (Lantus 17)

An instructional diagram showing a hand rotating the dosage knob on a pen injector labeled with dose markings such as 10, 20, and 30. The illustration indicates how to adjust the dose by turning the dial upward, useful for dosing accuracy in products like Lantus insulin.*

FDA Label Image

Figure (Lantus 18)

An instructional diagram showing a hand holding a syringe with the needle pointing to the left, indicated by a red arrow. The illustration appears to demonstrate proper syringe grip or injection technique, without displaying any product labeling or text.*

FDA Label Image

Figure (Lantus 19)

Instructional illustration showing a hand holding an insulin pen with an arrow indicating to press or push the pen. A circular timer icon with '10 secs' suggests holding or pressing for 10 seconds, likely demonstrating the administration step for Lantus insulin pen use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.